Andras Masszi, MD

Országos Onkológiai Intézet, Hungary

Poster(s):

• 1509 - Nemtabrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Cohort J of the Phase 2 BELLWAVE-003 Study